Investors

Share price

{{priceData.date}} {{priceData.time}}

{{priceData.currentPrice}} {{priceData.currency}}
Go to stock watch {{priceData.change}} {{priceData.currency}}

Quick links

Financial results Stock information Press releases and company announcements R&D pipeline Upcoming events

Novo Nordisk Annual Report

Cover page of the Novo Nordisk Annual Report 2023

Annual Report 2023

Latest news

{{'2024-12-12T13:47:54Z' | dateFormatFilter}}

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

Read more

{{'2024-12-06T18:11:09Z' | dateFormatFilter}}

The European Commission approves the acquisition of Catalent by Novo Holdings and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings

Read more

{{'2024-11-06T06:30:49Z' | dateFormatFilter}}

Novo Nordisk's sales increased by 23% in Danish kroner and by 24% at constant exchange rates to DKK 204.7 billion in the first nine months of 2024

Read more

News archive

Career Opportunities

Dear colleague

Please click here to go directly to our internal career site to view all our current job openings.

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.